A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery (LENIENT).
Mehrdad Golian, Mouhannad M Sadek, Alper Aydin...
https://pubmed.ncbi.nlm.nih.gov/36708911/Actively Recruiting
Led by Ottawa Heart Institute Research Corporation · Updated on 2026-07-07
6300
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating whether reducing arm movement restrictions after receiving Cardiac Implantable Electronic Devices CIED improves patient experience and lowers complication rates. This trial compares lenient versus strict arm restrictions following device surgery to develop standardized postoperative guidelines. The study uses a cluster crossover design to assess outcomes like lead dislodgement, device infection, hematoma, upper limb deep vein thrombosis, and frozen shoulder over one year. Participants are randomly assigned to receive either strict arm restrictions, which include no arm movement for 24 hours and no overhead arm movement or lifting heavier than 5 lbs for 8 weeks, or lenient restrictions that mainly limit shoveling and certain sports for shorter periods without overhead or weight limitations. Arm restriction instructions are delivered via nurses, printed summaries, electronic health records, and interactive voice reminders. The study cycles between these restriction protocols every 8 months. During the trial, patients receive standard follow-up through a device clinic and a 247 on-call nursing program. Researchers will monitor complications and patient quality of life using clinical assessments over one year. The primary outcome is a combination of lead dislodgement, frozen shoulder, upper arm venous thrombosis, and significant hematoma formation. Secondary outcomes include rates of hematoma, lead dislodgement, and frozen shoulder.
CONDITIONS
A Randomized Trial of Lenient Versus Strict Arm Instruction Post Cardiac Device Surgery
T
Tammy Knight
M
Mehrdad Golian
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ottawa Heart Institute Research Corporation
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 8 months per restriction period
Participants receive either strict or lenient arm movement restrictions after cardiac device surgery. Instructions and reminders are provided through nurses, printed summaries, electronic records, and voice calls. The study switches between restriction types every 8 months.
Duration - 1 year
Participants are monitored for complications such as lead dislodgement, frozen shoulder, venous thrombosis, and hematoma for one year after surgery through clinic visits and a 24/7 nursing program.
Regular follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mehrdad Golian, Mouhannad M Sadek, Alper Aydin...
https://pubmed.ncbi.nlm.nih.gov/36708911/Ottawa Heart Institute Research Corporation
Lead Sponsor